Moran Wealth Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Moran Wealth Management, LLC

  • $3.18 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$8.79 - $11.51 $19,601 - $25,667
-2,230 Reduced 1.1%
200,160 $2.29 Million
Q3 2023

Nov 13, 2023
BUY
$8.25 - $11.35 $43,386 - $59,689
5,259 Added 2.67%
202,390 $1.95 Million
Q2 2023

Aug 10, 2023
BUY
$10.1 - $11.6 $76,184 - $87,498
7,543 Added 3.98%
197,131 $2.1 Million
Q1 2023

May 10, 2023
BUY
$10.37 - $12.56 $393,997 - $477,204
37,994 Added 25.06%
189,588 $1.99 Million
Q4 2022

Feb 13, 2023
BUY
$9.9 - $12.43 $1.5 Million - $1.88 Million
151,594 New
151,594 $0

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Moran Wealth Management, LLC Portfolio

Follow Moran Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moran Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email